Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Jul 25, 2024 3:33pm
115 Views
Post# 36148616

Ollie Hinkle Heart Foundation

Ollie Hinkle Heart FoundationInteresting for Ventripoint remenber ( Ollie Hinkle Heart Foundation Will Introduce Ventripoint’s AIHeart-Imaging Diagnostic Technology to America’s Hospitals Toronto, Ontario – December 05, 2023 – One of the United States’ leading foundations, the Ollie Hinkle Heart Foundation (OHHF), has selected Ventripoint’s AI-powered heartimaging technology as one of three artificial intelligence systems it will be presenting to U.S. hospitals.)





One feature that has positioned OHHF as a leader in our industry is our commitment to collaboration. We're creating a network of partnerships with national and regional community organizations to provide the heart community with the tools and resources necessary to navigate caring for a child with a chronic illness.

We partner with like-minded organizations to expand our Reach, Resources, and Referrals to spread more love to more individuals impacted by childhood heart disease. Each partner brings directed support to the heart community, and through collaboration, we strengthen and complement each organization’s mission and lift our brands together. Partnering is an opportunity for our organizations to advance our collective causes while strengthening our missions, ensuring every heart warrior’s legacy lives on, and inspiring our community.

We cannot thank all of our partners enough for allowing us to do what we do for the heart community.

<< Previous
Bullboard Posts
Next >>